Monthly Archives: July 2017

BriaCell Appoints Top Oncologist and Opens Second Clinical Site for its Ongoing Clinical Trial in Advanced Breast Cancer
July 31, 2017

Berkeley, CA and Vancouver, BC – July 31, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Expands Targeted Pipeline via Acquisition of Sapientia Pharmaceuticals
July 24, 2017

Berkeley, CA and Vancouver, BC – July 24, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVax™ in Advanced Breast Cancer
July 19, 2017

Berkeley, CA and Vancouver, BC – July 19, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Completes Manufacturing of New Batch of BriaVax™
July 5, 2017

Berkeley, CA and Vancouver, BC – July 5, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...